Search

everythinglearnresearchcommunity

for

Search:↓

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.

Finasteride may cause lasting sexual, mental, and physical symptoms; use with caution.

Australian doctors experienced in adult transgender healthcare mostly prescribe intramuscular testosterone and oral estradiol, recommend mental health assessments before hormone therapy, and support improved training and guidelines.

Young men with early hair loss have slightly worse blood sugar and fat levels, suggesting possible health risks and need for monitoring.

Parathyroid hormones are important for hair growth, but their use in treating hair loss from chemotherapy is still uncertain.

SARS-CoV-2, the virus causing COVID-19, can affect all endocrine organs and systems, altering their function and potentially leading to disorders. Factors like diabetes and obesity increase infection risk and severity. Understanding these effects is key for effective treatment.

The document concludes that hormonal biomarkers are key for diagnosing hyperandrogenemia in women and hypogonadism in men.

Skin diseases linked to insulin resistance should be managed to prevent diabetes and reduce heart disease risk.

Changing the diagnosis criteria for PCOS might miss women at risk for related health issues.

The conclusion is that a thorough approach is needed to diagnose and manage hyperandrogenism in teenage girls, recognizing its major psychological and health effects.

Women with lichen planopilaris often have thyroid disease, depression, anxiety, and may respond to treatment with slowed disease progression.

Siblings with signs of virilization should be tested for non-classical congenital adrenal hyperplasia, which does not affect adult height but may impact fertility and well-being if untreated.

Early treatment and lifestyle changes are important for managing PCOS in young people to prevent long-term health issues.

Spironolactone plus finasteride works better for treating hirsutism.

New guidelines stress early diagnosis and lifestyle changes to manage metabolic syndrome and prevent complications.

ERβ has potential in treating prostate cancer and neurodegenerative diseases, but human studies are needed before clinical use.

Younger transgender women have surgery earlier, are mostly attracted to men, and show more preoperative depression that improves after surgery compared to older transgender women.

Chromium supplements don't help with weight loss or improve hormone and metabolism issues in people with polycystic ovary syndrome.

Many alopecia patients have undetected thyroid abnormalities that can be found through physical exams.

New treatments for PCOS focus on managing symptoms and improving fertility.

The conclusion is that standardizing testosterone measurement methods is essential for better diagnosis accuracy in women.

Diabetes can lead to blindness and skin problems, and managing blood sugar and blood pressure is crucial to prevent these complications.

Diagnosing PCOS in teenage girls is tricky and requires careful evaluation and management.

Topical L-thyroxine may help with wound healing and hair growth but should be used short-term due to potential risks.

Some men with early hair loss may have a male version of PCOS, affecting hormones and increasing health risks.

Eating less and exercising more, with personalized diet plans and realistic goals, can lead to weight loss and better health, but more research is needed for long-term success.

Hormonal therapies, like flutamide and cyproterone acetate, are safe and effective for treating adult women's acne, especially those with hormone imbalance or resistant acne.

Postmenopausal women with hyperandrogenism didn't have better metabolic health even after their testosterone levels became normal.

Ginger supplements helped reduce symptoms and improve metabolic health in hypothyroid patients.

Birth control pills containing cyproterone acetate improve the quality of life more for women with polycystic ovary syndrome after 6 months of use.